| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |